OnCo
termsTerm

Cytogenetics and karyotype

aka cytogenetic, karyotype, complex karyotype, monosomal karyotype, chromosomal abnormalities, high-risk cytogenetics, adverse cytogenetics, favourable cytogenetics, translocation, t(4;14), t(11;14), t(8;21), inv(16), hyperdiploid, hypodiploid, metaphase

Looking at a cancer's chromosomes under the microscope to find missing, extra, broken or swapped pieces. It has been the main risk-sorting tool in leukaemia, myeloma and lymphoma for decades.

Conventional karyotyping needs dividing cells and gives a whole-genome overview at low resolution; FISH targets specific abnormalities; NGS and optical genome mapping are replacing both. Cytogenetic risk groups drive treatment: t(8;21) and inv(16) AML are favourable and avoid transplant, complex or monosomal karyotypes are adverse; t(4;14), del(17p) and 1q gain define high-risk myeloma; hypodiploidy is adverse in childhood ALL; t(11;14) myeloma predicts venetoclax sensitivity. The Philadelphia chromosome t(9;22) is the founding example. Solid tumours use the same ideas for sarcoma translocations (EWSR1-FLI1) and 1p/19q co-deletion in oligodendroglioma.

Category
Pathology & biomarkers

Connected

12top

Pages like this

not linked directly; found by shared links